Browse > Article
http://dx.doi.org/10.3746/pnf.2017.22.3.166

Sargassum yezoense Extract Inhibits Carbohydrate Digestive Enzymes In Vitro and Alleviates Postprandial Hyperglycemia in Diabetic Mice.  

Park, Jae-Eun (Department of Food Science and Nutrition, Pusan National University)
Lee, Ji-Hee (Department of Food Science and Nutrition, Pusan National University)
Han, Ji-Sook (Department of Food Science and Nutrition, Pusan National University)
Publication Information
Preventive Nutrition and Food Science / v.22, no.3, 2017 , pp. 166-171 More about this Journal
Abstract
In this study, we investigated whether Sargassum yezoense extract (SYE) could inhibit ${\alpha}-glucosidase$ and ${\alpha}-amylase$ activities, and alleviate postprandial hyperglycemia in streptozotocin (STZ)-induced diabetic mice. Freeze-dried S. yezoense was extracted with 80% ethanol and concentrated for use in this study. The hypoglycemic effect was determined by evaluating the inhibitory activities of SYE against ${\alpha}-glucosidase$ and ${\alpha}-amylase$ as well as its ability to decrease postprandial blood glucose levels. The half-maximal inhibitory concentrations of SYE against ${\alpha}-glucosidase$ and ${\alpha}-amylase$ were $0.078{\pm}0.004$ and $0.212{\pm}0.064mg/mL$, respectively. SYE was a more effective inhibitor of ${\alpha}-glucosidase$ and ${\alpha}-amylase$ activities than the positive control, acarbose. The increase in postprandial blood glucose levels was significantly alleviated in the SYE group compared with that in the control group of STZ-induced diabetic mice. Furthermore, the area under the curves significantly decreased with SYE administration in STZ-induced diabetic mice. These results suggest that SYE is a potent inhibitor of ${\alpha}-glucosidase$ and ${\alpha}-amylase$ activities and alleviates postprandial hyperglycemia caused by dietary carbohydrates.
Keywords
Sargassum yezoense; ${\alpha}-glucosidase$; ${\alpha}-amylase$; postprandial hyperglycemia; diabetic mice;
Citations & Related Records
Times Cited By KSCI : 2  (Citation Analysis)
연도 인용수 순위
1 Fonseca V. 2003. Clinical significance of targeting postprandial and fasting hyperglycemia in managing type 2 diabetes mellitus. Curr Med Res Opin 19: 635-641.   DOI
2 Hanefeld M. 1998. The role of acarbose in the treatment of non-insulin-dependent diabetes mellitus. J Diabetes Complications 12: 228-237.   DOI
3 Kang JY, Khan MN, Park NH, Cho JY, Lee MC, Fujii H, Hong YK. 2008. Antipyretic, analgesic, and anti-inflammatory activities of the seaweed Sargassum fulvellum and Sargassum thunbergii in mice. J Ethnopharmacol 116: 187-190.   DOI
4 Pushpamali WA, Nikapitiya C, De Zoysa M, Whang I, Kim SJ, Lee J. 2008. Isolation and purification of an anticoagulant from fermented red seaweed Lomentaria catenata. Carbohydr Polym 73: 274-279.   DOI
5 Kwon MJ, Nam TJ. 2006. Porphyran induces apoptosis related signal pathway in AGS gastric cancer cell lines. Life Sci 79: 1956-1962.   DOI
6 Hong IS, Kim GA, Park JK, Boo SM. 2008. Morphology and phenology of Sargassum yezoense (Sargassaceae, Phaeophyceae). Korean Journal of Nature Conservation 2: 132-139.
7 Nakai M, Kageyama, N, Nakahara K, Miki W. 2006. Phlorotannins as radical scavengers from the extract of Sargassum ringgoldianum. Mar Biotechnol 8: 409-414.   DOI
8 Reddy P, Urban S. 2009. Meroditerpenoids from the southern Australian marine brown alga Sargassum fallax. Phytochemistry 70: 250-255.   DOI
9 Jung M, Jang KH, Kim B, Lee BH, Choi BW, Oh KB, Shin J. 2008. Meroditerpenoids from the brown alga Sargassum siliquastrum. J Nat Prod 71: 1714-1719.   DOI
10 Seo Y, Park KE, Kim YA, Lee HJ, Yoo JS, Ahn JW, Lee BJ. 2006. Isolation of tetraprenyltoluquinols from the brown alga Sargassum thunbergii. Chem Pharm Bull 54: 1730-1733.   DOI
11 Kim SN, Choi HY, Lee W, Park GM, Shin WS, Kim YK. 2008. Sargaquinoic acid and sargahydroquinoic acid from Sargassum yezoense stimulate adipocyte differentiation through $PPAR{\alpha}$/${\gamma}$ activation in 3T3-L1 cells. FEBS Lett 582: 3465-3472.   DOI
12 Yuan YV, Walsh NA. 2006. Antioxidant and antiproliferative activities of extracts from a variety of edible seaweeds. Food Chem Toxicol 44: 1144-1150.   DOI
13 Prashanth D, Padmaja R, Samiulla DS. 2001. Effect of certain plant extracts on ${\alpha}$-amylase activity. Fitoterapia 72: 179-181.   DOI
14 Watanabe J, Kawabata J, Kurihara H, Niki R. 1997. Isolation and identification of ${\alpha}$-glucosidase inhibitors from tochucha (Eucommia ulmoides). Biosci Biotechnol Biochem 61: 177-178.   DOI
15 Zheng J, He J, Ji B, Li Y, Zhang X. 2007. Antihyperglycemic activity of Prunella vulgaris L. in streptozotocin-induced diabetic mice. Asia Pac J Clin Nutr 16: 427-431.
16 Kim JS. 2004. Effect of Rhemanniae Radix on the hyperglycemic mice induced with streptozotocin. J Korean Soc Food Sci Nutr 33: 1133-1138.   DOI
17 Lee EH, Ham J, Ahn HR, Kim MC, Kim CY, Pan CH, Um BH, Jung SH. 2009. Inhibitory effects of the compounds isolated from Sargassum yezoense on ${\alpha}$-glucosidase and oxidative stress. Kor J Pharmacogn 40: 150-154.
18 Koskinen P, Manttari M, Manninen V, Huttunen JK, Heinonen OP, Frick MH. 1992. Coronary heart disease incidence in NIDDM patients in the Helsinki Heart Study. Diabetes Care 15: 820-825.   DOI
19 Lebovitz HE. 1992. Oral antidiabetic agents: the emergence of ${\alpha}$-glucosidase inhibitors. Drugs 3: 21-28.
20 Tadera K, Minami Y, Takamatsu K, Matsuoka T. 2006. Inhibition of ${\alpha}$-glucosidase and ${\alpha}$-amylase by flavonoids. J Nutr Sci Vitaminol 52: 149-153.   DOI
21 Ceriello A, Davidson J, Hanefeld M, Leiter L, Monnier L, Owens D, Tajima N, Tuomilehto J; International Prandial Glucose Regulation Study Group. 2006. Postprandial hyperglycaemia and cardiovascular complications of diabetes: an update. Nutr Metab Cardiovasc Dis 16: 453-456.   DOI
22 Ceriello A. 2005. Postprandial hyperglycemia and diabetes complications: is it time to treat?. Diabetes 54: 1-7.   DOI
23 Inoue I, Takahashi K, Noji S, Awata T, Negishi K, Katayama S. 1997. Acarbose controls postprandial hyperproinsulinemia in non-insulin dependent diabetes mellitus. Diabetes Res Clin Pract 36: 143-151.   DOI
24 Stern JL, Hagerman AE, Steinberg PD, Mason PK. 1996. Phlorotannin-protein interactions. J Chem Ecol 22: 1877-1899.   DOI
25 Zimmet P, Alberti KGMM, Shaw J. 2001. Global and societal implications of the diabetes epidemic. Nature 414: 782-787.   DOI
26 Muoio DM, Newgard CB. 2006. Obesity-related derangements in metabolic regulation. Annu Rev Biochem 75: 367-401.   DOI
27 Baron AD. 1998. Postprandial hyperglycaemia and ${\alpha}$-glucosidase inhibitors. Diabetes Res Clin Pract 40: S51-S55.   DOI
28 UK Prospective Diabetes Study (UKPDS) Group. 1998. Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). Lancet 352: 837-853.   DOI
29 Saito N, Sakai H, Suzuki S, Sekihara H, Yajima Y. 1998. Effect of an ${\alpha}$-glucosidase inhibitor (voglibose), in combination with sulphonylureas, on glycaemic control in type 2 diabetes patients. J Int Med Res 26: 219-232.   DOI
30 Lebovitz HE. 2002. Treating hyperglycemia in type 2 diabetes: new goals and strategies. Cleve Clin J Med 69: 809-820.   DOI
31 Carroll MF, Gutierrez A, Castro M, Tsewang D, Schade DS. 2003. Targeting postprandial hyperglycemia: a comparative study of insulinotropic agents in type 2 diabetes. J Clin Endocrinol Metab 88: 5248-5254.   DOI